Magnetic Nanoparticle Facilitated Drug Delivery for Cancer Therapy with Targeted and Image-Guided Approaches

被引:234
作者
Huang, Jing [1 ]
Li, Yuancheng [1 ]
Orza, Anamaria [1 ]
Lu, Qiong [2 ]
Guo, Peng [3 ,4 ]
Wang, Liya [1 ]
Yang, Lily [5 ]
Mao, Hui [1 ]
机构
[1] Emory Univ, Sch Med, Dept Radiol & Imaging Sci, Atlanta, GA 30322 USA
[2] Cent S Univ, Xiangya Hosp 2, Dept Pharm, Changsha 410011, Hunan, Peoples R China
[3] CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA
[4] Boston Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA
[5] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA
关键词
IRON-OXIDE NANOPARTICLES; GROWTH-FACTOR RECEPTOR; PH-RESPONSIVE NANOCARRIERS; MRI CONTRAST ENHANCEMENT; FV ANTIBODY FRAGMENT; IN-VIVO; THERANOSTIC NANOPARTICLES; HYDROTHERMAL SYNTHESIS; PHOTOTHERMAL THERAPY; LOADED MICROBUBBLES;
D O I
10.1002/adfm.201504185
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
With rapid advances in nanomedicine, magnetic nanoparticles (MNPs) have emerged as a promising theranostic tool in biomedical applications, including diagnostic imaging, drug delivery and novel therapeutics. Significant preclinical and clinical research has explored their functionalization, targeted delivery, controllable drug release and image-guided capabilities. To further develop MNPs for theranostic applications and clinical translation in the future, we attempt to provide an overview of the recent advances in the development and application of MNPs for drug delivery, specifically focusing on the topics concerning the importance of biomarker targeting for personalized therapy and the unique magnetic and contrast-enhancing properties of theranostic MNPs that enable image-guided delivery. The common strategies and considerations to produce theranostic MNPs and incorporate payload drugs into MNP carriers are described. The notable examples are presented to demonstrate the advantages of MNPs in specific targeting and delivering under image guidance. Furthermore, current understanding of delivery mechanisms and challenges to achieve efficient therapeutic efficacy or diagnostic capability using MNP-based nanomedicine are discussed.
引用
收藏
页码:3818 / 3836
页数:19
相关论文
共 174 条
[1]   Enhanced noscapine delivery using uPAR-targeted optical-MR imaging trackable nanoparticles for prostate cancer therapy [J].
Abdalla, Mohamed O. ;
Karna, Prasanthi ;
Sajja, Hari Krishna ;
Mao, Hui ;
Yates, Clayton ;
Turner, Timothy ;
Aneja, Ritu .
JOURNAL OF CONTROLLED RELEASE, 2011, 149 (03) :314-322
[2]   Generating improved single-chain Fv molecules for tumor targeting [J].
Adams, GP ;
Schier, R .
JOURNAL OF IMMUNOLOGICAL METHODS, 1999, 231 (1-2) :249-260
[3]   Factors affecting the clearance and biodistribution of polymeric nanoparticles [J].
Alexis, Frank ;
Pridgen, Eric ;
Molnar, Linda K. ;
Farokhzad, Omid C. .
MOLECULAR PHARMACEUTICS, 2008, 5 (04) :505-515
[4]   Triggered Release from Liposomes through Magnetic Actuation of Iron Oxide Nanoparticle Containing Membranes [J].
Amstad, Esther ;
Kohlbrecher, Joachim ;
Mueller, Elisabeth ;
Schweizer, Thomas ;
Textor, Marcus ;
Reimhult, Erik .
NANO LETTERS, 2011, 11 (04) :1664-1670
[5]   Doxil® - The first FDA-approved nano-drug: Lessons learned [J].
Barenholz, Yechezkel .
JOURNAL OF CONTROLLED RELEASE, 2012, 160 (02) :117-134
[6]   Laboratory formulated magnetic nanoparticles for enhancement of viral gene expression in suspension cell line [J].
Bhattarai, Shanta Raj ;
Kim, Sun Young ;
Jang, Kyu Yun ;
Lee, Ki Chang ;
Yi, Ho Keun ;
Lee, Dae Yeol ;
Kim, Hak Yong ;
Hwang, Pyoung Han .
JOURNAL OF VIROLOGICAL METHODS, 2008, 147 (02) :213-218
[7]  
Campbell RB, 2002, CANCER RES, V62, P6831
[8]   Novel water-soluble and pH-responsive anticancer drug nanocarriers: Doxorubicin-PAMAM dendrimer conjugates attached to superparamagnetic iron oxide nanoparticles (IONPs) [J].
Chang, Yulei ;
Meng, Xinlei ;
Zhao, Yili ;
Li, Kun ;
Zhao, Bao ;
Zhu, Ming ;
Li, Yapeng ;
Chen, Xuesi ;
Wang, Jingyuan .
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2011, 363 (01) :403-409
[9]  
Chauhan VP, 2012, NAT NANOTECHNOL, V7, P383, DOI [10.1038/NNANO.2012.45, 10.1038/nnano.2012.45]
[10]   Anti-HER2 antibody and ScFvEGFR-conjugated antifouling magnetic iron oxide nanoparticles for targeting and magnetic resonance imaging of breast cancer [J].
Chen, Hongwei ;
Wang, Liya ;
Yu, Qiqi ;
Qian, Weiping ;
Tiwari, Diana ;
Yi, Hong ;
Wang, Andrew Y. ;
Huang, Jing ;
Yang, Lily ;
Mao, Hui .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2013, 8 :3781-3794